Sign in

CIK 0000926617

  • Non-accelerated filer
  • Smaller reporting company

Aspira Women's Health Inc.

Sign in to watch
Ticker
AWHL
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330595156
Phone
+1 512-519-0400
Business address
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
Former names
VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-12-02 Fraser John D Director Grant or award · Stock Option (Right to Buy) +314,811 314,811
2025-09-17 Fraser John D Director Purchase +16,389 $0.45 $7K 566,393
2025-09-17 Fraser John D Director Purchase · Warrant (Right to Buy) +12,292 12,292
2025-09-17 Fraser John D Director Purchase +16,389 $0.45 $7K 566,393
2025-09-17 Fraser John D Director Purchase · Warrant (Right to Buy) +12,292 981,549

Page 1 of 1 · 5 trades